Претраживање
Приказ резултата 41-42 од 42
Disease specific patient-reported outcome (pro) instruments for hematologic malignancies (hm)
(Elsevier Science Inc, New York, 2019)
Patient-reported outcomes used in clinical trials of systemic lupus erythematosus: a review of suitability for FDA labelling claims
(Elsevier Science Inc, New York, 2019)